In this review, we have evaluated the role of transcription factor Blimp-1 in bridging metabolism and antioxidant pathways in chronic inflammatory diseases, including diabetes, cardiovascular disease, and autoimmune diseases. Here, PRDM1 is linked to cardiovascular disorder.